1. Home
  2. CLDI vs MSS Comparison

CLDI vs MSS Comparison

Compare CLDI & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • MSS
  • Stock Information
  • Founded
  • CLDI 2014
  • MSS 2019
  • Country
  • CLDI United States
  • MSS United States
  • Employees
  • CLDI N/A
  • MSS N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • MSS
  • Sector
  • CLDI Health Care
  • MSS
  • Exchange
  • CLDI Nasdaq
  • MSS Nasdaq
  • Market Cap
  • CLDI 20.2M
  • MSS 16.2M
  • IPO Year
  • CLDI N/A
  • MSS 2023
  • Fundamental
  • Price
  • CLDI $1.60
  • MSS $0.99
  • Analyst Decision
  • CLDI
  • MSS Strong Buy
  • Analyst Count
  • CLDI 0
  • MSS 1
  • Target Price
  • CLDI N/A
  • MSS $4.00
  • AVG Volume (30 Days)
  • CLDI 484.3K
  • MSS 358.7K
  • Earning Date
  • CLDI 11-11-2025
  • MSS 09-26-2025
  • Dividend Yield
  • CLDI N/A
  • MSS N/A
  • EPS Growth
  • CLDI N/A
  • MSS N/A
  • EPS
  • CLDI N/A
  • MSS 0.07
  • Revenue
  • CLDI N/A
  • MSS $124,217,480.00
  • Revenue This Year
  • CLDI N/A
  • MSS N/A
  • Revenue Next Year
  • CLDI N/A
  • MSS N/A
  • P/E Ratio
  • CLDI N/A
  • MSS $13.18
  • Revenue Growth
  • CLDI N/A
  • MSS 114.01
  • 52 Week Low
  • CLDI $1.51
  • MSS $0.68
  • 52 Week High
  • CLDI $46.68
  • MSS $2.08
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 30.60
  • MSS 51.59
  • Support Level
  • CLDI $1.51
  • MSS $0.88
  • Resistance Level
  • CLDI $1.68
  • MSS $1.72
  • Average True Range (ATR)
  • CLDI 0.10
  • MSS 0.17
  • MACD
  • CLDI 0.14
  • MSS 0.01
  • Stochastic Oscillator
  • CLDI 22.97
  • MSS 19.25

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: